Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Upstream Bio (UPB) Operating Expenses (2023 - 2025)

Historic Operating Expenses for Upstream Bio (UPB) over the last 3 years, with Q3 2025 value amounting to $38.5 million.

  • Upstream Bio's Operating Expenses rose 9752.31% to $38.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $143.3 million, marking a year-over-year increase of 11080.42%. This contributed to the annual value of $80.1 million for FY2024, which is 8857.72% up from last year.
  • Per Upstream Bio's latest filing, its Operating Expenses stood at $38.5 million for Q3 2025, which was up 9752.31% from $45.3 million recorded in Q2 2025.
  • Upstream Bio's 5-year Operating Expenses high stood at $45.3 million for Q2 2025, and its period low was $10.0 million during Q3 2023.
  • For the 3-year period, Upstream Bio's Operating Expenses averaged around $24.6 million, with its median value being $19.5 million (2024).
  • As far as peak fluctuations go, Upstream Bio's Operating Expenses soared by 8221.24% in 2024, and later skyrocketed by 15088.09% in 2025.
  • Upstream Bio's Operating Expenses (Quarter) stood at $14.8 million in 2023, then soared by 82.21% to $26.9 million in 2024, then surged by 43.02% to $38.5 million in 2025.
  • Its Operating Expenses was $38.5 million in Q3 2025, compared to $45.3 million in Q2 2025 and $32.6 million in Q1 2025.